IVERMECTIN and PANCREATIC CANCER - Ivermectin outperforms chemotherapy in 2022 South Korean Study

According to the 2022 South Korean study by Lee et al: "it is necessary to discover novel chemotherapeutic agents and develop effective therapeutic strategies in pancreatic cancer."


"This is the first study to evaluate the anticancer effects of the combination of Ivermectin and gemcitabine in pancreatic cancer."

"We found that the ivermectin–gemcitabine combination treatment suppressed pancreatic cancer more effectively than gemcitabine alone treatment." 

"In vivo experiments confirmed that the ivermectin–gemcitabine group had significantly suppressed tumor growth compared to the gemcitabine alone group".

"These results indicate that ivermectin exerts synergistic effects with gemcitabine, preventing pancreatic cancer progression, and could be a potential antitumor drug for the treatment of pancreatic cancer."

Related: 

New & Improved Joe Tippens Protocol - Dr William Makis

The holy grail turbo cancer cure may just be the synergistic combination therapy of Fenbendazole AND Ivermectin as follows:

Adapted from: https://makismd.substack.com/p/ivermectin-and-cancer-part-2-treating 


Comments

Labels

Show more

Archive

Show more

Popular posts from this blog

Fenbendazole Joe Tippens Protocol: A Step-by-Step Guide (2024)

FENBENDAZOLE in Stage 4 Cancers - the 2021 Stanford University Case Series

Fenbendazole: Questions Answered, Things to Know, Useful Tips - Ben Fen

Fenbendazole Cancer Success Stories and Treatment Testimonials: Case Series Compilation (2024)

12 Types of Zinc Supplementation and Absorption 2024

Ivermectin and Fenbendazole: Treating Turbo Cancer - Dr William Makis

FENBENDAZOLE and CANCER - at least 12 Anti-Cancer Mechanisms of Action - Dr William Makis (2024)

Lifewave Review: A Critical Look at the Phototherapy Patches (2024)

NAC vs NAD vs NR vs NMN? What are the Differences?

Lumbrokinase vs Nattokinase vs Serrapeptase: What's the Difference?